Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced...
Change of Director's Interest Notices x 4
Filed with ASX · · 12 pages · English
Release
Radiopharm Theranostics Limited on 6ix
Earlier from Radiopharm Theranostics
- Notification of cessation of securities - RAD
- Non-Compliance with Listing Rule 10.11
- Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
- RAD Completes Meeting with US FDA for Development of RAD101
- Change of Director's Interest Notice (RC)
Later from Radiopharm Theranostics
- Notification regarding unquoted securities - RAD
- Radiopharm receives $8M advance on FY26 R&D tax incentive
- Notice of Annual General Meeting/Proxy Form
- Quarterly Activities/Appendix 4C Cash Flow Report
- RAD Alignment with US FDA for Development of RAD101
